US and Israel-based medical device company SuperDimension yesterday closed its series B round with $11m of investment from US-based healthcare provider Covidien Ventures, and undisclosed existing investors. SuperDimension’s last round of funding raised $9.8m, in July 2010, from backers including investment firm OrbiMed Advisors, and venture capital firms Oxford Biosciences Partners, Pitango Venture Capital and Medica Venture Partners. Alongside the equity funding, SuperDimension also gained a $15m credit facility from the Oxford Finance Corporation in September 2010. SuperDimension develops catheter-based diagnostic products for use in combating disease, lung cancer in particular. The capital will be invested in improving SuperDimension’s commercial infrastructure and expanding its sales and marketing teams.

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?